MAZE
#2129
Maze Therapeutics, Inc. - Common Stock
27.2 2 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.73%
Variación mensual
+9.32%
Variación en los últimos 6 meses
-1.59%
Cambio anual
-39.55%
Cierres anteriores
27.7 0
Open
27.5 4
Mínimo
26.9 5
Máximo
28.2 4
Financials
- Market Capitalization 1.51 B
- Employee 141
- Founded 2017
- CEO N/A
- Website www.mazetx.com
- Headquarter Delaware, United States
- FIGI BBG00NHJHS27
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1971 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 131.09 USD | -2.45% | +1.24% | -12.69% | +77.51% | 1.89 B USD | ||
| 2048 |  GENB Generate Biomedicines, Inc. - Common Stock | 13.06 USD | -5.64% | -6.11% | -16.97% | -12.93% | 1.68 B USD | ||
| 2180 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 29.13 USD | -3.38% | -4.21% | -34.24% | +11.23% | 1.40 B USD | ||
| 2823 |  CBIO Crescent Biopharma, Inc. - Common Stock | 13.99 USD | -3.25% | -0.71% | -28.26% | +38.10% | 519.64 M USD |